Twist Bioscience (NASDAQ:TWST) just reported results for the second quarter of 2024.
- Twist Bioscience reported earnings per share of -79 cents. This was above the analyst estimate for EPS of -81 cents.
- The company reported revenue of $75.30 million.
- This was 6.58% better than the analyst estimate for revenue of $70.65 million.